| Authors: |
van Dyk J; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Waitt C; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.; Department of Women's and Children's Health, University of Liverpool, Liverpool, United Kingdom., Mugerwa H; Joint Clinical Research Centre, Lubowa, Uganda., Wiesner L; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Orrell C; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.; HIV and Infectious Diseases Unit, South African Medical Research Council, Cape Town, South Africa., Bamford A; Medical Research Council Clinical Trials Unit at University College London, London, England, United Kingdom.; Infection, Immunity & Inflammation Department, UCL Great Ormond Street Hospital Institute of Child Health, London, United Kingdom., Gibb DM; Medical Research Council Clinical Trials Unit at University College London, London, England, United Kingdom., McIlleron HM; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Colbers A; Department of Pharmacy, Pharmacology & Toxicology, Radboud University Medical Center, Nijmegen, the Netherlands., Burger DM; Department of Pharmacy, Pharmacology & Toxicology, Radboud University Medical Center, Nijmegen, the Netherlands., Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Wasmann RE; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa. |
